REBINYN

Novo Nordisk Canada Inc🇨🇦 Health Canada

Approval Id: 67e6b4e6baac7723
Drug Approval Canada Name: REBINYN
Product Name: REBINYN
Status: Marketed
Status Date: 2018-03-23
Original Market Date: 2018-03-23
Din: 02470268
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD04 COAGULATION FACTOR IX
Atc Name: b 02 bd 04
Aig Number: 0159770002
Company Name: Novo Nordisk Canada Inc
Company Address: 101-2476 Argentia Road, Mississauga, Ontario, Canada, L5N 6M1

COAGULATION FACTOR IX (RECOMBINANT), PEGYLATED

1000 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

67e6b4e6baac7723

Type

Standard